Conventional versus automated measurement of blood pressure in primary care patients with systolic hypertension: randomised parallel design controlled trial

Martin G Myers, Marshall Godwin, Martin Dawes, Alexander Kiss, Sheldon W Tobe, F Curry Grant, Janusz Kaczorowski, Martin G Myers, Marshall Godwin, Martin Dawes, Alexander Kiss, Sheldon W Tobe, F Curry Grant, Janusz Kaczorowski

Abstract

Objective: To compare the quality and accuracy of manual office blood pressure and automated office blood pressure using the awake ambulatory blood pressure as a gold standard.

Design: Multi-site cluster randomised controlled trial.

Setting: Primary care practices in five cities in eastern Canada.

Participants: 555 patients with systolic hypertension and no serious comorbidities under the care of 88 primary care physicians in 67 practices in the community.

Interventions: Practices were randomly allocated to either ongoing use of manual office blood pressure (control group) or automated office blood pressure (intervention group) using the BpTRU device. The last routine manual office blood pressure (mm Hg) was obtained from each patient's medical record before enrollment. Office blood pressure readings were compared before and after enrollment in the intervention and control groups; all readings were also compared with the awake ambulatory blood pressure.

Main outcome measure: Difference in systolic blood pressure between awake ambulatory blood pressure minus automated office blood pressure and awake ambulatory blood pressure minus manual office blood pressure.

Results: Cluster randomisation allocated 31 practices (252 patients) to manual office blood pressure and 36 practices (303 patients) to automated office blood pressure measurement. The most recent routine manual office blood pressure (149.5 (SD 10.8)/81.4 (8.3)) was higher than automated office blood pressure (135.6 (17.3)/77.7 (10.9)) (P < 0.001). In the control group, routine manual office blood pressure before enrollment (149.9 (10.7)/81.8 (8.5)) was reduced to 141.4 (14.6)/80.2 (9.5) after enrollment (P < 0.001/P = 0.01), but the reduction in the intervention group from manual office to automated office blood pressure was significantly greater (P < 0.001/P = 0.02). On the first study visit after enrollment, the estimated mean difference for the intervention group between the awake ambulatory systolic/diastolic blood pressure and automated office blood pressure (-2.3 (95% confidence interval -0.31 to -4.3)/-3.3 (-2.7 to -4.4)) was less (P = 0.006/P = 0.26) than the difference in the control group between the awake ambulatory blood pressure and the manual office blood pressure (-6.5 (-4.3 to -8.6)/-4.3 (-2.9 to -5.8)). Systolic/diastolic automated office blood pressure showed a stronger (P < 0.001) within group correlation (r = 0.34/r = 0.56) with awake ambulatory blood pressure after enrollment compared with manual office blood pressure versus awake ambulatory blood pressure before enrollment (r = 0.10/r = 0.40); the mean difference in r was 0.24 (0.12 to 0.36)/0.16 (0.07 to 0.25)). The between group correlation comparing diastolic automated office blood pressure and awake ambulatory blood pressure (r = 0.56) was stronger (P < 0.001) than that for manual office blood pressure versus awake ambulatory blood pressure (r = 0.30); the mean difference in r was 0.26 (0.09 to 0.41). Digit preference with readings ending in zero was substantially reduced by use of automated office blood pressure.

Conclusion: In compliant, otherwise healthy, primary care patients with systolic hypertension, introduction of automated office blood pressure into routine primary care significantly reduced the white coat response compared with the ongoing use of manual office blood pressure measurement. The quality and accuracy of automated office blood pressure in relation to the awake ambulatory blood pressure was also significantly better when compared with manual office blood pressure. Trial registration Clinical trials NCT 00214053.

Trial registration: ClinicalTrials.gov NCT00214053.

Conflict of interest statement

Competing interests: All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.

Figures

https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4788049/bin/myem774471.f1_default.jpg
Fig 1 Flow diagram showing recruitment of family physicians and patients into trial. ABPM=24 hour ambulatory blood pressure monitoring; AOBP=automated office blood pressure; MOBP=manual office blood pressure
https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4788049/bin/myem774471.f2_default.jpg
Fig 2 Mean of office blood pressure (BP) and awake ambulatory BP readings plotted against difference between these readings, using Bland-Altman format. Shows data for awake ambulatory BP versus routine manual office (MO) BP readings before enrolment (top panels), AOBP readings after enrolment (bottom left panel), and MOBP readings after enrolment (bottom right panel). Horizontal lines indicate two standard deviations around the mean difference. Values for estimated mean bias (2 SD) are shown

References

    1. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Recommendations for blood pressure measurement in humans and experimental animals part 1: blood pressure measurement in humans—a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension 2005;45:142-61.
    1. Myers MG, Godwin M, Dawes M, Kiss A, Tobe S, Kaczorowski J. Measurement of blood pressure in the office—recognizing the problem and proposing the solution. Hypertension 2010;55:195-200.
    1. Reeves RA. Does this patient have hypertension? How to measure blood pressure. JAMA 1995;273:1211-6.
    1. Pickering TG, Gerin W, Schwartz JE, Spruill TM, Davidson KW. Should doctors still measure blood pressure? The missing patients with masked hypertension. J Hypertens 2008;26:2259-67.
    1. Sala C, Santin A, Rescaldani M, Magrini F. How long shall the patient rest before clinic blood pressure measurement? Am J Hypertens 2006;19:713-7.
    1. Giles TD, Egan P. Pay (adequately) for what works: the economic undervaluation of office and ambulatory blood pressure recordings. J Clin Hypertension 2008;10:257-9.
    1. Parati G, Omboni S, Bilo G. Why is out-of-office blood pressure measurement needed? Hypertension 2009;54:181-7.
    1. Verdecchia P, Angeli F, Mazzota G, Gentile G, Reboldi G. Home blood pressure measurements will not replace 24-hour ambulatory blood pressure monitoring. Hypertension 2009;54:188-95.
    1. Stergiou GS, Siontis KCM, Ioannidis JPA. Home blood pressure as a cardiovascular outcome predictor: it’s time to take this method seriously. Hypertension 2010;55:1301-3
    1. Verdecchia P, Clement D, Fagard R, Palatini P, Parati G. Target-organ damage, morbidity and mortality. Blood Press Monit 1999;4:303-17.
    1. Staessen JA, Byttebier G, Buntinx F, Celis H, O’Brien ET, Fagard R. Antihypertensive treatment based on conventional or ambulatory blood pressure measurement: a randomized controlled trial. JAMA 1997;278:1065-72.
    1. Wright JM, Mattu GS, Perry TL Jr, Gelfer ME, Strange KD, Zorn A, et al. Validation of new algorithm for the BPM-100 electronic oscillometric office blood pressure monitor. Blood Press Monit 2001;6:161-5.
    1. White WG, Anwar YA. Evaluation of the overall efficacy of the Omron office digital blood pressure HEM-907 monitor in adults. Blood Press Monit 2001;6:107-10.
    1. Stergiou GS, Tzamouranis D, Protogerou A, Nasothimiou E, Kapralos C. Validation of Microlife Watch BP Office Professional device for office blood pressure measurement according to the international protocol. Blood Press Monit 2008;13:299-303.
    1. Beckett L, Godwin M. The BpTRU automatic blood pressure monitor compared to 24-h ambulatory blood pressure monitoring in the assessment of blood pressure in patients with hypertension. BMC Cardiovasc Disord 2005;5:18.
    1. Myers MG, Valdivieso M, Kiss A. Use of automated office blood pressure measurement to reduce the white coat response. J Hypertens 2009;27:280-6.
    1. Myers MG. Automated blood pressure measurement in routine clinical practice. Blood Press Monit 2006;11:59-62.
    1. Ishikawa J, Nasothimiou E, Karpettas N, Feltheimer S, McDoniel S, Schwartz J, et al. Automatic office blood pressure measurement without doctors or nurses present is more predictive of ambulatory blood pressure than is office blood pressure by mercury sphygmomanometer. J Hypertens 2009;27(suppl 4):170S.
    1. Myers MG, Valdivieso M, Kiss A. Optimum frequency of automated blood pressure measurements using an automated sphygmomanometer. Blood Press Monit 2008;13:333-8
    1. O’Brien E, Mee F, Atkins N, O’Malley K. Accuracy of the SpaceLabs 90207 determined by the British Hypertension Society Protocol. J Hypertens 1991;9(suppl 5):25-31S.
    1. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
    1. Donner A, Klar N. Design and analysis of cluster randomization trials in health research. Oxford University Press, 2000.
    1. Godwin M, Birtwhistle R, Delva D, Lam M, Casson I, MacDonald S, et al. Manual and automated office measurements in relation to awake ambulatory blood pressure monitoring. Fam Pract 2011;28:110-7.
    1. Myers MG. A proposed algorithm for diagnosing hypertension using automated office blood pressure measurement. J Hypertens 2010;28:703-8.
    1. O’Brien E. Has conventional sphygmomanometry ended with the banning of mercury? Blood Press Monit 2002;7:37-40.
    1. Scientific Committee on Emerging and Newly Identified Health Risks. Mercury sphygmomanometers in healthcare and the feasibility of alternatives. SCENIHR, 2009.
    1. Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, Laragh JH. How common is white coat hypertension? JAMA 1988,259:225-8.
    1. Myers MG, Valdivieso M, Kiss A, Tobe SW. Comparison of two automated sphygmomanometers for use in the office setting. Blood Press Monit 2009;14:45-7.
    1. Myers MG, Valdivieso M, Kiss A. Consistent relationship between automated office blood pressure recorded in different settings. Blood Press Monit 2009;14:108-11.
    1. Myers MG, Valdivieso M, Chessman M, Kiss A. Can sphygmomanometers designed for self-measurement of blood pressure in the home be used in office practice? Blood Press Monit 2010;15:300-4.
    1. Head GA, Mihailidou AS, Duggan KA, Beilin LJ, Berry N, Brown MA, et al. Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort study. BMJ 2010;340:1104-11.
    1. Myers MG, Valdivieso MA. Use of an automated blood pressure recording device, the BpTRU, to reduce the “white coat effect” in routine practice. Am J Hypertens 2003;16:494-7.
    1. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25:1105-87
    1. O’Brien E. Ambulatory blood pressure measurement: the case for implementation in primary care. Hypertension 2008;51:1435-41.

Source: PubMed

3
Se inscrever